Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
143
days
RRS1 regulates proliferation, migration, and invasion of HTR-8/SVneo human trophoblasts
AuthorsYixuan Wu; Yao Li; Jing Wang; Qianying Guo; Wei Chen; Jie Qiao; Liying Yan; Peng Yuan
Affiliations1. Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China; 2. National Clinical Research Center for Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China; 3. Key Laboratory of Assisted Reproduction, Peking University, Ministry of Education, Beijing, China; 4. State Key Laboratory of Female Fertility Promotion, Beijing, China; 5. Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China
148
days
Innovation and development of stent retrievers in acute ischemic stroke
AuthorsNan Zhang; Hongye Xu; Hongjian Zhang; Hongyu Ma; Weilong Hua; Minghao Song; Yongxin Zhang; Jianmin Liu; Lei Zhang; Xiaoxi Zhang; Pengfei Yang
Affiliations1. Oriental Pan-Vascular Devices Innovation College, University of Shanghai for Science and Technology, Shanghai, China; 2. Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China; 3. No. 904 Hospital of the PLA Joint Logistics Support Force, Wuxi, China
72
days
Precision medicine for advanced biliary tract cancer in China: current status and future perspectives
AuthorsZhen Huang; Wen Zhang; Yongkun Sun; Dong Yan; Xijie Zhang; Lu Liang; Hong Zhao
Affiliations1. Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; 2. Department of Internal Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; 3. Department of Intervention, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; 4. Value & Implementation, Global Medical & Scientific Affairs, MSD China, Shanghai, China
188
days
Albumin-bound paclitaxel plus anlotinib in patients with recurrent, platinum-resistant primary epithelial ovarian cancer (A-Plus): a phase II, single-arm, prospective study
AuthorsYun Zhou; Jian Zhou; Yin Wang; Ji-Bin Li; Rongzhen Luo; Chanjuan Zeng; Yingxin He; Yanfang Li
Affiliations1. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China; 2. Department of Gynecology, Sun Yat-sen University Cancer Center, Guangzhou, China; 3. Department of Imaging, Sun Yat-sen University Cancer Center, Guangzhou, China; 4. Department of GCP, Sun Yat-sen University Cancer Center, Guangzhou, China; 5. Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China
144
days
Perspective on strengthening dementia prevention and control system: a comprehensive framework for national health
AuthorsBin Cong; Hengge Xie; Yongan Sun; Jingnian Ni; Jing Shi; Mingqing Wei; Fuyao Li; Huali Wang; Luning Wang; Bin Qin; Jing Cheng; Demin Han; Wei Xiao; Boli Zhang; Jinzhou Tian
Affiliations1. Department of Pathogen Biology, Institute of Basic Medicine, Hebei Medical University, Shijiazhuang, China; 2. Department of Geriatric Neurology, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China; 3. Department of Neurology, Peking University First Hospital, Beijing, China; 4. Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, National Center of Medicine (Brain Disorders), Beijing, China; 5. Institute for Brain and Cognitive Disorders, Beijing University of Chinese Medicine, Beijing, China; 6. Institute of Traditional Chinese Medicine/National Key Laboratory, Beijing University of Chinese Medicine, Beijing, China; 7. Dementia Care and Research Center, Clinical Research Division, Peking University Institute of Mental Health (Sixth Hospital), Beijing, China; 8. Department of Neurology, The Second Medical Center, National Clinical Research Center for Geriatric Disease, Chinese PLA General Hospital, Beijing, China; 9. Department of Neurology, Institute of Geriatric Medicine, Beijing Hospital, National Center of Gerontology, Beijing, China; 10. Department of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing, China; 11. Department of Otolaryngology, Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China; 12. Jiangsu Kanion Pharmaceutical Co. Ltd. and State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Lianyungang, China; 13. State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China
99
days
Global, regional and national burden and trends of congenital musculoskeletal and limb deformities among under-5 children from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021
AuthorsQinglin Yang; Zhuanmei Jin; Yongping Wang
Affiliations1. The First Clinical Medical College of Lanzhou University, Lanzhou, China; 2. Department of Orthopedics, the Second Affiliated Hospital of Hainan Medical University, Haikou, China
110
days
Particulate matter exposure and end-stage renal disease risk in IgA nephropathy
AuthorsYilin Chen; Huan Zhou; Siqing Wang; Lingqiu Dong; Yi Tang; Wei Qin
Affiliations1. Division of Nephrology, Department of Medicine, West China Hospital, Sichuan University, Chengdu, China
113
days
Predictive biomarkers for immunotherapy in nasopharyngeal carcinoma: from tumor microenvironment to macroenvironment
AuthorsSaiwei Huang; Yelin Liang; Na Liu; Jun Ma
Affiliations1. Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China; 2. Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
130
days
Exogenous spexin aggravates renal ischemia reperfusion injury and triggers toxicity in healthy kidneys
AuthorsKadri Kulualp; Meltem Kumaş Kulualp; Zeynep Semen; Gökçen Güvenç Bayram; Aslı Çelik; Melek Yeşim Ak; Osman Yilmaz
Affiliations1. Department of Surgery, Faculty of Veterinary Medicine, Dokuz Eylül University, Izmir, Turkey; 2. Department of Histology and Embryology, Faculty of Veterinary Medicine, Dokuz Eylül University, Izmir, Turkey; 3. Department of Biochemistry, Faculty of Veterinary Medicine, Dokuz Eylül University, Izmir, Turkey; 4. Department of Physiology, Faculty of Veterinary Medicine, Dokuz Eylül University, Izmir, Turkey; 5. Multidisciplinary Experimental Animal Laboratory, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey; 6. Department of Histology and Embryology, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey
154
days
China’s biosafety/biosecurity governance: evolution, challenges, and architecture design
AuthorsKaiyuan Min; Yi Zhang; Jiangfeng Liu; Juntao Yang; Feng Cao; Zongchao Peng; Depei Liu
Affiliations1. State Key Laboratory of Common Mechanism Research for Major Diseases, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, China; 2. Vanke School of Public Health, Tsinghua University, Beijing, China; 3. School of Public Policy and Management, Tsinghua University, Beijing, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days